WCG has announced its acquisition of The Avoca Group. With the addition of The Avoca Group, WCG expands its portfolio of solutions focused on improving patient access. Moving forward, The Avoca Group will be known as WCG Avoca, and will retain its leadership structure along with its headquarters in Princeton, NJ.
For more information, click here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.